<DOC>
	<DOCNO>NCT00584883</DOCNO>
	<brief_summary>To determine maximum tolerate dose ABT 510 administer concurrent radiation therapy patient newly diagnose glioblastoma multiforme .</brief_summary>
	<brief_title>A Phase I Study ABT 510 Newly Diagnosed Glioblastoma Multiforme</brief_title>
	<detailed_description>1 . To describe toxicity associate regimen adult patient newly diagnose glioblastoma multiforme . 2 . To determine duration disease free survival overall survival associate therapy . 3 . Evaluate thrombospondin 1 ( TSP-1 ) 2 ( TSP-2 ) tumor vs. correspond normal tissue use quantitative real time Polymerase Chain Reaction ( Q-RT-PCR ) . 4 . Determine effect ABT 510 tumor permeability tumor blood volume measure non-invasive Magnetic Resonance Imaging ( MRI ) .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<criteria>1 . Patients must 19 year age old . 2 . Patients must histologically prove newly diagnose glioblastoma multiforme . 3 . Patients must fully recover immediate postoperative period maintain stable corticosteroid regimen 5 day prior entry . 4 . Patients must Karnofsky performance status &gt; 60 % ( i.e . patient must able care himself/herself occasional help others ) . 5 . Patients must adequate hematologic , renal liver function ( i.e . Absolute neutrophil count &gt; 1500/mm3 , Platelets &gt; 100,000/mm3 , creatinine 1.5 mg/dl . 6 . Women childbearing potential must negative pregnancy test . 7 . Patients potential pregnancy impregnate partner must agree follow acceptable birth control method avoid conception . The effect investigational drug develop human fetus know , drug likely harmful develop fetus nursing infant . Women childbearing potential must agree use adequate contraception ( either surgical sterilization ; approve hormonal contraceptive birth control pill DepoProvera , Lupron Depot ; barrier method condom diaphragm along spermicide ; Intrauterine device ( IUD ) ) . Should woman become pregnant suspect pregnant participating study , inform treat physician study PI immediately . 8 . The patient able selfadminister caregiver reliably administer subcutaneous injection . 9 . Ability understand willingness sign write informed consent document . 1 . Pregnant breast feeding . 2 . Prior therapy brain tumor ( except surgery ) 3 . Prior treatment antineoplastic agent . 4 . Exclude sexually active male female unwilling practice contraception study . 5 . Serious concurrent infection . 6 . Clinically significant cardiac disease well control medication ( e.g . congestive heart failure , symptomatic coronary artery disease cardiac arrhythmia ) myocardial infarction within last 12 month . 7 . Patients prior cytotoxic chemotherapy prior radiation therapy . 8 . Patients serious uncontrolled comorbid disease investigator feel may comprise study finding . 9 . Patients must able learn self administer another person administer subcutaneous ( SQ ) injection . 10 . Patients receive investigational agent within 28 day prior Day 1 study .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Patients newly diagnose brain tumor</keyword>
</DOC>